Overview

Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of Flavangenol® (Toyo Shinyaku, Japan), a pine bark extract, in lowering blood pressure and improving glycemic control and plasma lipoprotein profile.
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Collaborator:
Funded by Toyo Shinyaku Co Ltd
Treatments:
Pycnogenols